What is Lenalid 25mg (LENALIDOMIDE)?
IMiD for multiple myeloma, myelodysplastic syndrome (del 5q MDS), mantle cell lymphoma, and follicular lymphoma. Thalidomide derivative with better safety profile.
How it Works
Binds CRBN E3 ubiquitin ligase, promoting degradation of Ikaros and Aiolos — depletes myeloma survival signals and enhances T and NK cell immune responses.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | LENALIDOMIDE |
| Dose per Tablet | 25MG |
| Pack Size | 12×10 (120 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Myelosuppression (neutropenia, thrombocytopenia), DVT/PE (mandatory prophylaxis), fatigue, diarrhea, rash, peripheral neuropathy.
Safety Warnings
⚠️ TERATOGENIC — mandatory REMS program with regular pregnancy testing. DVT/PE prophylaxis mandatory. CBC weekly for first 8 weeks. Dose reduction in renal impairment.
🌏 International shipping: 7–14 days
